nVerses Capital’s MetLife MET Stock Holding History

nVerses Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,479	Closed	-$387K	–	454
2026 Q1	$387K	Buy	+5,479	New	+$410K	0.35%	102
2024 Q2	–	Sell	-100	Closed	-$7.41K	–	1128
2024 Q1	$7.41K	Buy	+100	New	+$6.97K	0.02%	527

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

nVerses Capital's MET Position: Q2 2026 in Review

nVerses Capital sold out of MetLife (MET) in Q2 2026, closing a stake of 5,479 shares — an estimated $387K sold.

nVerses Capital first reported a position in MET in Q1 2024 and held it in 2 quarters. The position peaked at $387K in Q1 2026. 1,215 funds tracked by Wall St. Rank hold MET as of Q2 2026.

nVerses Capital reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 5,479 MetLife shares in Q2 2026, an estimated $387K.
nVerses Capital first reported a position in MetLife in Q1 2024 and held it in 2 quarters.
nVerses Capital's MetLife position peaked at $387K in Q1 2026.
1,215 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.